← Back to Search

Behavioural Intervention

Yoomi Physical Therapy Software for Inpatient Mobility (YOOMI Trial)

N/A
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-discharge
Awards & highlights

YOOMI Trial Summary

This trial tests if playing a game can help hospitalized patients exercise & stay mobile, preserving their pre-hospitalization ability.

Who is the study for?
This trial is for patients aged 65 or older who are in the hospital and can read and speak English. They must be able to consent, enrolled in the HELP program, and have no medical reasons preventing them from doing exercises in bed. People with unstable psychiatric illnesses, critical illness needing ICU care, recent surgery, bed rest orders, or surgical tubes cannot join.Check my eligibility
What is being tested?
The study is testing a new gamified physical therapy software called Yoomi designed to help hospitalized patients exercise by themselves while lying in bed. The goal is to see if this fun approach can maintain their muscle strength and function during their hospital stay.See study design
What are the potential side effects?
Since Yoomi involves physical activity within one's own capacity and under safety guidelines, side effects might include typical exercise-related issues such as muscle soreness or fatigue.

YOOMI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Satisfaction Score for Intervention Group Questionnaire (change is being assessed)
Percentage of exercise repetitions completed for Intervention Group (change is being assessed)
Software Utilization Time for Intervention Group (change is being assessed)
Secondary outcome measures
3DCAM Delirium Scale
Change in Activity Measure for Post Acute Care (AMPAC) Scores
Length of hospital stay
+3 more

YOOMI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gamified Physical Therapy Exercise Software Intervention + Usual CareExperimental Treatment1 Intervention
Participants randomized to the intervention group will be asked each day by a volunteer whether they would like to use the gamified physical therapy exercise software while in their beds. Participants willing to exercise will have the device set up for them to participate by a volunteer and the software will begin with a tutorial video for different exercises and then ask patients to perform in sequence with prompting and motion tracking. Exercises include Frontal Bicep Curls, Arm Crosses, Press Ups, Arm Rotations, and Basketball Shots.
Group II: Usual CareActive Control1 Intervention
Usual Care

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,152 Total Patients Enrolled

Media Library

Yoomi Physical Therapy Software (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05815017 — N/A
Sedentary Lifestyle Research Study Groups: Gamified Physical Therapy Exercise Software Intervention + Usual Care, Usual Care
Sedentary Lifestyle Clinical Trial 2023: Yoomi Physical Therapy Software Highlights & Side Effects. Trial Name: NCT05815017 — N/A
Yoomi Physical Therapy Software (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05815017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this research project?

"Clinicaltrials.gov confirms that this trial, originally posted on May 1st 2023, is now closed to new enrollees. Despite the closure of this medical study, 422 other trials are currently open and seeking participants."

Answered by AI
~40 spots leftby Dec 2024